Active Ingredient: GLUCAGON
Proprietary Name: BAQSIMI
Dosage Form; Route of Administration: POWDER; NASAL
Strength: 3MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210134
Product Number: 001
Approval Date: Jul 24, 2019
Applicant Holder Full Name: AMPHASTAR PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
